Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omega 3 Prescription Drug Approved in Japan - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Omega 3 Prescription Drug Approved in Japan

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Pronova BioPharma ASA and Takeda Pharmaceutical Co. Ltd. have received approval from the Japanese Ministry of Health, Labour and Welfare regarding a New Drug Application (NDA) for Lotriga granular capsule 2g (omega 3 acid ethyl esters 90) for the treatment of hyperlipidemia.
Lotriga, discovered by Pronova, is the omega 3-derived prescription drug containing highly concentrated and purified EPA and DHA. It is already on the market in 60 countries including the U.S. and Europe. In 2005, Takeda and Pronova entered into a license and supply agreement in which Takeda was granted the exclusive development and marketing right to this product in Japan. Lotriga will be the first prescription medicine in Japan that contains both EPA and DHA.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics